CDSCO approval is required before drugs, medical devices, and related products can be manufactured or sold in India. The regulation ensures safety, quality, and compliance with healthcare ...
The Central Drugs Standard Control Organisation (CDSCO) has launched a new risk classification module on the drug regulator's online system for medical devices in order to simplify the regulatory ...
Manisha Singh and Pankaj Musyuni of LexOrbis discuss regulatory changes for medical device companies and the impact of COVID-19 on manufacturers India is Asia's fourth largest medical device market ...
The Central Drugs Standard Control Organisation (CDSCO) has announced risk classification of 119 medical devices pertaining to radiotherapy under the Medical Devices Rules (MDR), 2017, as part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results